Gurton · International journal of sport nutrition and exercise metabolism 2024 · randomized crossover trial · n=10

Oral but Not Topical Sodium Bicarbonate Improves Repeated Sprint Performance During Simulated Soccer Match Play Exercise in Collegiate Athletes.

Cited 4 times in the scientific literature.

Level 2 - randomized trial

Double-blind, block randomized crossover trial in humans

PubMed 39222921 · doi:10.1123/ijsnem.2024-0059 · record verified 2026-08-29

What was done

Ten collegiate male soccer players participated in a block randomized, double-blind, crossover trial completing a 90-minute simulated soccer field test (SAFT90) under three conditions: oral sodium bicarbonate (0.3 g/kg body mass in capsules; SB-ORAL), topical sodium bicarbonate (0.9036 g/kg body mass PR Lotion; SB-LOTION), or matched placebo capsules and lotion (PLA). Soccer-specific performance tests (countermovement jumps, Illinois agility, 8 × 25 m repeated sprints) and blood acid-base and electrolyte variables (pH, HCO3-, Na+, K+) were measured before, at half-time, and after the SAFT90 protocol.

What was found

SB-ORAL resulted in significantly faster average sprint times compared to PLA during half-time (3.7% quicker; p = .049; g = .57) and post-SAFT90 (4.9% quicker; p = .041; g = .66). SB-ORAL increased blood pH and HCO3- pre-warmup and at half-time (p < .05) and lowered K+ at half-time (p = .035) versus PLA. SB-LOTION increased pH (p = .019) and lowered K+ (p = .012) at half-time, and increased Na+ post-exercise (p = .008) compared with PLA, but showed no sprint performance improvements. Numerical results for jump and agility tests were not reported in the abstract.

Why it matters

This study demonstrates that oral sodium bicarbonate enhances repeated sprint capacity during soccer-specific exercise via increased blood buffering capacity, whereas topical application does not elicit ergogenic benefits despite minor blood chemistry changes.

Limits

The sample size was very small (n = 10) and limited to male collegiate players, restricting generalizability to females and elite cohorts. Results for countermovement jumps and agility tests were omitted from the abstract, gastrointestinal symptoms were not reported, and simulated match play cannot fully replicate competitive match conditions.

Cited by